Terms: = Pancreatic cancer AND TPM4, P67936, 7171, ENSG00000167460 AND Prognosis
1 results:
1. Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.
Zhou X; Zhu X; Yao J; Wang X; Wang N
Invest New Drugs; 2021 Dec; 39(6):1469-1483. PubMed ID: 33983530
[TBL] [Abstract] [Full Text] [Related]
